Human CD30 Monoclonal Antibody
Product Sizes
1 mg
£268.00
YR0005-1MG
5 mg
£746.00
YR0005-5MG
20 mg
£1442.00
YR0005-20MG
About this Product
- SKU:
- YR0005
- Additional Names:
- D1S166E|Ki-1|TNFRSF8
- Application:
- Block/Inhibit/Neutralise, Cell-based/Functional Assay, ELISA
- Clonality:
- Monoclonal
- Extra Details:
- Brentuximab is a biosimilar directed against the extracellular domain of CD30. The brentuximab antibody selectively targets tumor cells expressing the cell membrane protein CD30 and delivers the MMAE, which causes apoptosis by preventing cell cycle progression of the G2 to M phase through disruption of the cytosolic microtuble network, thereby preventing tumor growth and proliferation.
- Formulation:
- Purified from cell culture supernatant in an animal-free facility
- Immunogen:
- CD30
- Isotype:
- IgG1, kappa
- Molecular Weight:
- 150 kDa
- Purity:
- >95%
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Supplier:
- ABclonal Technology
- Type:
- Antibody: Biosimilar Antibody
- Manufacturer's Data Sheet:YR0005
